Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PRIALT safely and effectively. See full prescribing information for PRIALT. PRIALT (ziconotide) solution, intrathecal infusion Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine.
- generic_name
- ziconotide acetate
- product_names
- ziconotide acetate
- ndc
- 68118-723, 68118-723-10, 68118-720, 68118-720-10, 68118-722, 68118-722-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en